Addus HomeCare Corporation $ADUS Shares Sold by Sterling Capital Management LLC

Sterling Capital Management LLC cut its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 35.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,464 shares of the company’s stock after selling 7,777 shares during the quarter. Sterling Capital Management LLC owned 0.08% of Addus HomeCare worth $1,355,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Leeward Investments LLC MA raised its holdings in shares of Addus HomeCare by 9.4% during the first quarter. Leeward Investments LLC MA now owns 120,857 shares of the company’s stock valued at $11,318,000 after acquiring an additional 10,414 shares during the period. Burney Co. purchased a new stake in shares of Addus HomeCare in the 4th quarter valued at approximately $1,841,000. Capital Research Global Investors boosted its stake in Addus HomeCare by 9.0% in the 3rd quarter. Capital Research Global Investors now owns 1,201,560 shares of the company’s stock worth $141,772,000 after purchasing an additional 99,262 shares during the period. Vanguard Group Inc. boosted its stake in Addus HomeCare by 2.9% in the 3rd quarter. Vanguard Group Inc. now owns 1,298,104 shares of the company’s stock worth $153,163,000 after purchasing an additional 36,674 shares during the period. Finally, 8 Knots Management LLC purchased a new position in Addus HomeCare during the 3rd quarter worth approximately $6,075,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ADUS has been the subject of a number of research analyst reports. Wall Street Zen lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 21st. Weiss Ratings downgraded Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 22nd. Barclays dropped their price target on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a research report on Friday, May 15th. Finally, Citizens Jmp reissued a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Monday, May 18th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Addus HomeCare currently has an average rating of “Moderate Buy” and an average price target of $131.00.

Addus HomeCare Stock Up 1.1%

Addus HomeCare stock opened at $98.05 on Tuesday. Addus HomeCare Corporation has a twelve month low of $87.95 and a twelve month high of $124.43. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83. The firm has a market cap of $1.83 billion, a PE ratio of 18.12, a P/E/G ratio of 1.33 and a beta of 0.89. The firm’s 50 day moving average price is $94.33 and its two-hundred day moving average price is $101.53.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The company had revenue of $363.50 million during the quarter, compared to analyst estimates of $366.41 million. During the same quarter last year, the business posted $1.42 EPS. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. On average, research analysts predict that Addus HomeCare Corporation will post 6.24 EPS for the current fiscal year.

Insider Activity

In related news, insider Heather Brianne Dixon sold 288 shares of Addus HomeCare stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the sale, the insider owned 44,371 shares of the company’s stock, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 966 shares of company stock worth $90,168 in the last ninety days. 4.10% of the stock is currently owned by company insiders.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.